P.15M4&EQ~NAGW$XJ@K)X|QU.>;Q]K
SYSTEM PROCESSING...
P.15M4&EQ~NAGW$XJ@K)X|QU.>;Q]K
SYSTEM PROCESSING...
Posted: 2025-04-23 18:55:01 UTC
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
We use a score to evaluate content reliability. This article's score is high enough, and there are no largely false claims identified in this rollup.
Status
Last Updated
2025-04-23 18:55:12 UTC
Verified By
Rollup News
A trial of gantenerumab showed a clinically meaningful slowing of disease onset in asymptomatic people with dominantly inherited Alzheimer's disease, despite a negative primary outcome.
Gantenerumab shows potential in slowing the onset of Alzheimer's disease.
The study focused on asymptomatic individuals with a genetic predisposition to Alzheimer's.
The primary outcome of the trial was negative, indicating mixed results.